Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McGill University
$105,000.00
The Role of the Cellular Energy Sensor AMP-Activated Protein Kinase (AMPK) in Breast Cancer Metastasis and Chemoresistance
FY 2017-18
Summary
The majority of mortality in breast cancer patients derives from metastasis, the spread of tumour cells to other organs such as the brain, and from resistance to the drugs used to treat this disease. The gaps in our knowledge of how these two processes occur impede the treatment of late-stage cancer. One aspect of cell biology shown to be crucial in the development of early-stage tumours is metabolism, or how cells use molecular fuels to produce energy and the building blocks needed for replication. However, the types of metabolic strategies used by metastasizing and drug-resistant cancer cells are not well understood. We propose to address these problems, specifically by investigating a protein critical for the control of metabolism, adenosine monophosphate-activated protein kinase (AMPK). AMPK acts as a cellular energy sensor, allowing the cell to respond appropriately to the environment, such as by reducing energy expenditure when fuel is scarce. Both metastasis and chemotherapeutic drug treatment present cancer cells with metabolic challenges, by, respectively, introducing them to new environments within the body that may not have access to the nutrients they require, and creating energetically stressful alterations within the cell. Preliminary research in the Jones lab has suggested that AMPK activity may be connected to both metastasis and drug resistance. This project will consequently elucidate how exactly this protein affects cancer cell metabolism during metastasis and drug treatment, and in so doing will open up potential new avenues of treatment for these highly clinically relevant conditions.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
383385
Name
Rabinovitch Rebecca
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The Role of the Cellular Energy Sensor AMP-Activated Protein Kinase (AMPK) in Breast Cancer Metastasis and Chemoresistance
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Ampk; Breast Cancer; Cancer; Chemoresistance; Chemotherapy; Metabolism; Metastasis; Mitochondria; Oncometabolism; P53
Abstract
The majority of mortality in breast cancer patients derives from metastasis, the spread of tumour cells to other organs such as the brain, and from resistance to the drugs used to treat this disease. The gaps in our knowledge of how these two processes occur impede the treatment of late-stage cancer. One aspect of cell biology shown to be crucial in the development of early-stage tumours is metabolism, or how cells use molecular fuels to produce energy and the building blocks needed for replication. However, the types of metabolic strategies used by metastasizing and drug-resistant cancer cells are not well understood. We propose to address these problems, specifically by investigating a protein critical for the control of metabolism, adenosine monophosphate-activated protein kinase (AMPK). AMPK acts as a cellular energy sensor, allowing the cell to respond appropriately to the environment, such as by reducing energy expenditure when fuel is scarce. Both metastasis and chemotherapeutic drug treatment present cancer cells with metabolic challenges, by, respectively, introducing them to new environments within the body that may not have access to the nutrients they require, and creating energetically stressful alterations within the cell. Preliminary research in the Jones lab has suggested that AMPK activity may be connected to both metastasis and drug resistance. This project will consequently elucidate how exactly this protein affects cancer cell metabolism during metastasis and drug treatment, and in so doing will open up potential new avenues of treatment for these highly clinically relevant conditions.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Rabinovitch, Rebecca
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~